CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hall, B. A.
Right arrow Articles by Sprung, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hall, B. A.
Right arrow Articles by Sprung, J.
Canadian Journal of Anesthesia 53:989-993 (2006)
© Canadian Anesthesiologists' Society, 2006

General Anesthesia

Case report: Intraoperative anaphylactoid reaction and hydroxyethyl starch in balanced electrolyte solution (Hextend®)

[Présentation de cas : réaction anaphylactoïde peropératoire et amidon hydroxyéthylé dans une solution d’électrolyte balancée (Hextend®)]

Brian A. Hall, MD*, Evangelo Frigas, MD{dagger}, Damir Matesic, MD{dagger}, Michael D. Gillett, MD{ddagger} and Juraj Sprung, MD PhD*

* From the Department of Anesthesiology, the
{dagger} Division of Allergic Diseases and Internal Medicine, and the
{ddagger} Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

Address correspondence to: Dr. Juraj Sprung, Professor of Anesthesiology, Department of Anesthesiology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. Phone: 507-255-3298; Fax: 507-255-6463; E-mail: Sprung.juraj{at}mayo.edu

Purpose: To report a first case of probable anaphylactoid reaction to 6% hydroxyethyl starch reconstituted in balanced electrolyte and glucose solution (Hextend®).

Clinical features: A 22-yr-old man was admitted for a partial nephrectomy. Near the end of the four-hour operation, an infusion of Hextend® was initiated. Shortly thereafter, mechanical ventilation became difficult, peak inspiratory pressure increased to 55 cm H2O with audible wheezing over the patient’s lungs. Blood pressure suddenly decreased to 68/46 mmHg. Multiple doses of phenylephrine, ephedrine and epinephrine were required to restore the patient’s blood pressure. Postoperatively, a diffuse urticarial rash was apparent on his upper torso. The patient recovered uneventfully. His postoperative serum tryptase was 26.3 ng·mL–1 (reference range, < 11.5 ng·mL–1) and the urine N-methyl-histamine was 2448 µg·g–1 creatinine (reference range, 30–200 µg·g–1 creatinine). Two months after the event, skin testing was conducted to test for possible allergy to latex, lidocaine, propofol, cisatracurium, succinylcholine, vecuronium, midazolam, fentanyl, ondansetron, neostigmine, and cephazolin, and all were negative. Hextend® was also tested, starting with a 1:100,000 dilution and the results were negative.

Conclusions: The temporal relationship of severe hypotension, bronchospasm and skin rash within ten minutes from administration of Hextend® in this patient suggests an immediate hypersensitivity reaction to hetastarch. The elevated levels of serum tryptase and urinary N-methyl-histamine suggest that this hypersensitivity was mediated from mast cell degranulation. Negative skin testing suggests that the reaction was anaphylactoid.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Canadian Anesthesiologists' Society.